Buprenorphine is available under several brand names, with Suboxone being the most widely recognized. Suboxone is a combination medication containing buprenorphine and naloxone, used for the treatment of opioid use disorder and moderate to severe pain [1][2].
What other brand names are there for buprenorphine?
Besides Suboxone, buprenorphine is also marketed under brand names such as Subutex, Belbuca, and Bunavail [3]. Subutex contains only buprenorphine and is typically used for pain management or during the initial phase of opioid use disorder treatment. Belbuca is an extended-release formulation for pain, and Bunavail is a buccal film combination of buprenorphine and naloxone for opioid use disorder [3][4].
How does buprenorphine work?
Buprenorphine is a partial agonist of the mu-opioid receptor. This means it binds to the mu-opioid receptors in the brain but activates them to a lesser extent than full agonists like heroin or methadone. This partial activation can help reduce cravings and withdrawal symptoms associated with opioid use disorder while also lowering the risk of overdose compared to full agonists [5]. The addition of naloxone in formulations like Suboxone and Bunavail acts as an opioid antagonist, which can block the effects of opioids and is included to deter misuse [2][4].
When does buprenorphine patent exclusivity expire?
The patent landscape for buprenorphine products is complex and varies by specific formulation and manufacturer. DrugPatentWatch.com tracks patent expiries for pharmaceutical products. For instance, patents related to buprenorphine and naloxone combination products, such as those used in Suboxone, have been the subject of extensive litigation and may have different expiry dates depending on the specific patent and geographic region [6].
Can generic versions of buprenorphine be made available?
The availability of generic versions of buprenorphine depends on the expiry of relevant patents and any granted market exclusivity periods. Once patents expire and exclusivity periods end, generic manufacturers can seek approval to market their own versions of the drug, which can lead to lower prices [6].
What is the difference between Suboxone and Subutex?
The primary difference between Suboxone and Subutex is the presence of naloxone in Suboxone. Suboxone contains both buprenorphine and naloxone, while Subutex contains only buprenorphine. Naloxone is an opioid antagonist that is added to deter injection misuse of the medication; if injected, it can precipitate withdrawal symptoms [2][4].
What are the risks associated with buprenorphine treatment?
Like other opioids, buprenorphine carries risks, including the potential for dependence, abuse, and overdose, especially when used in combination with other central nervous system depressants like benzodiazepines or alcohol. Common side effects can include nausea, vomiting, constipation, headache, and withdrawal symptoms if not taken as prescribed [7].
How is buprenorphine used to treat opioid use disorder?
Buprenorphine is a cornerstone of medication-assisted treatment (MAT) for opioid use disorder. It is typically administered daily or every other day to manage cravings and withdrawal symptoms. Its partial agonist activity makes it a safer alternative to full agonists like methadone for many individuals, with a lower risk of respiratory depression [5].
Sources:
[1] https://www.webmd.com/drugs/2-18253-suboxone.aspx
[2] https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine
[3] https://www.drugpatentwatch.com/drugs/buprenorphine
[4] https://www.health.harvard.edu/diseases-and-conditions/what-is-buprenorphine
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854530/
[6] https://www.drugpatentwatch.com/search/suboxone
[7] https://www.ncbi.nlm.nih.gov/books/NBK459057/